US$ 22.49
nourish glp 1 Nutrition Care Startup Raises $100 Million to Help GLP-1 Treatment Menlo Ventures leads $100M round
Description
The Cardiovascular Biology of Glucagon-like Peptide-1

As well as exploring new diseases impacted by metabolic medicines, a raft of new drugs that build on semaglutides success are on the way

Retatrutide has also demonstrated promising results in liver health

Patients receiving GLP-1 therapy demonstrated lower rates of advanced adenomas on surveillance colonoscopy, a finding particularly relevant given that adenoma prevention formed the evidentiary backbone for aspirins adoption in earlier prevention strategies
